For instance, Kojima et al. (2016) demonstrated that the blocking antibodies of the CD47 protein attenuated the severity of atherosclerosis in mouse models by improving the phagocytosis capacity of immune cells and enhanced the clearance of abnormal cells from mouse vascular tissues. The gene discussed is CD47; the disease is atherosclerosis.